From September 20, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.27 CNY | +1.63% | +14.62% | +12.30% |
Apr. 22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.30% | 6.65B | |
+13.21% | 8.15B | |
-0.47% | 7.23B | |
-6.99% | 3.72B | |
-7.20% | 3.64B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-43.12% | 863M | |
-15.02% | 799M | |
-17.77% | 788M |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.